Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01348126 · ClinicalTrials.gov registry record · Phase 2
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
A Phase 2 study, sponsored by Synta Pharmaceuticals.
- Terminated
- Registry status
- Phase 2
- Development phase
- 385
- Enrollment target
NCT01348126: Clinical Trial Phase 2 study, sponsored by Synta Pharmaceuticals.
NCT01348126 is a Phase 2 study that was terminated before completion, run by Synta Pharmaceuticals. The registered enrollment target is 385 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (189% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01348126, a Phase 2 study, was terminated before completion, sponsored by Synta Pharmaceuticals.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 385 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether combining ganetespib (STA-9090) with docetaxel is more effective than docetaxel alone in the treatment of subjects with advanced non-small cell lung cancer.
Interventions
- DRUG Docetaxel
- DRUG Combination of ganetespib and docetaxel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 385 participants |
| Start Date | 2011-05 |
| Est. Completion | 2015-10 |
| Phase | Phase 2 |
Why NCT01348126 stopped before completion
NCT01348126 is an interventional study that assigns participants to a tested intervention. The registered 385 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (189% higher).
The record links to 0 conditions, and to 2 interventions - of which Docetaxel is the first listed.
NCT01348126 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01348126 about?
NCT01348126 is a clinical study titled "Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer". The purpose of this study is to determine whether combining ganetespib (STA-9090) with docetaxel is more effective than docetaxel alone in the treatment of subjects with advanced non-small cell lung cancer.
What is the current status of trial NCT01348126?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 385 participants. The study started on 2011-05. Estimated completion is 2015-10.
What interventions are being tested in trial NCT01348126?
The interventions under investigation include: Docetaxel (DRUG), Combination of ganetespib and docetaxel (DRUG).
Who is sponsoring clinical trial NCT01348126?
This trial is sponsored by Synta Pharmaceuticals, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01348126's enrollment target sits among peer trials
385 109th of 2000 higher than 1,890 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05373823 · 385 participants · NA
MySmartSkin Online Skin Self-exam Intervention for Melanoma Survivors
- NCT05503173 · 385 participants · NA
Telehealth for Pain and Unhealthy Drinking Among PLWH
- NCT06226883 · 385 participants · Phase 2
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
- NCT06290063 · 385 participants · Phase 2
Cannabidiol and Older Adult Cannabis Users
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia